StaveMD Tirzepatide Review: Monthly Price & Refund Cutoff

StaveMD’s current tirzepatide page lists $249 month to month and a $199 monthly equivalent on its longest plan. The quoted bundle covers provider review, the prescription and shipping without a separate membership fee. Its current refund page also says cancellation is available from the account without a notice period, with an important exception for a month whose medication has already been ordered.¹²

The current flexible price and written refund exception make the offer easier to compare. The longest-plan payment total, actual billing interval and individual pharmacy still need confirmation before purchase.

Which StaveMD price applies?

The medication-specific page is more useful than the general GLP-1 banners. It distinguishes $249 month to month from $199 per month on the longest plan. The same page describes no dose-based price increase and no separate membership fee. A $199 equivalent does not establish the first amount charged, the plan duration or installment availability.¹

Ask for the longest plan’s total payment, supply duration and refund treatment before choosing it. Someone new to the service may value a smaller initial commitment even when its periodic price is higher. A patient already comfortable with the service may make a different decision, but should still know what happens if medical needs change before a longer plan ends.

For approved medication alternatives, our Zepbound cost guide helps compare product presentation and manufacturer eligibility. StaveMD’s compounded offer is a different finished product; a smaller quoted price does not establish equivalent evidence or the same fulfillment conditions.

What is included in care?

The current product page includes provider review, medication and shipping in the quoted price. A licensed clinician decides whether the patient qualifies, and completing the intake does not guarantee a prescription. StaveMD describes cash-pay treatment, so insurance coverage is not required for its published offer.¹

Our tirzepatide dosing and side-effect guide can help prepare questions about clinical follow-up. Ask how continued monitoring works after the first review. Find out who responds to symptoms, when another clinical assessment is needed and how refills are authorized. A clear initial price is useful, but the ability to reach the treating team matters throughout treatment. Confirm whether laboratory work or additional appointments could create separate costs.

The current cancellation and refund rule

The current refund page says patients can cancel from their account at any time without a notice period. It permits a refund request at any time except for a month whose medication has already been ordered. If a clinician decides treatment is inappropriate and no medication is ordered, it describes a full refund.²

The practical deadline is therefore the pharmacy-order point, not the day the parcel arrives. Ask when the next month is ordered and whether the account shows that status. Keep confirmation of cancellation and any refund request. A right to stop future purchases does not establish a refund for medication already committed under the policy.

Older materials described a different advance notice rule and more restrictive prepayment treatment. The current published policy is the basis of this review. If checkout presents a conflicting agreement, resolve that conflict in writing before paying, particularly for the longest plan.

Confirm the dispensing pharmacy and eligibility

The current page refers to a licensed U.S. compounding pharmacy without establishing the individual facility for every prescription. Earlier materials named Red Rock, but that should not be treated as a guaranteed current assignment. Ask for the actual pharmacy name, destination-state eligibility, formulation and any added ingredients before fulfillment.

When transferring treatment, supply the existing prescription and history to the clinician. Do not assume a new vial has the same concentration or instructions because it contains tirzepatide. The pharmacist should explain the supplied product and label. Ask what happens if a delivery is delayed or appears damaged and who can authorize a replacement.

How to weigh the compounded option

Our compounded tirzepatide guide explains the medication distinction. Compounded products are not FDA-approved; FDA advises that compounding should be used only when the patient’s medical needs cannot be met by an approved drug.³ Brand-trial results do not independently establish the performance of the particular compounded prescription.

StaveMD’s page identifies its advertised trial outcomes as results from branded-drug research rather than StaveMD patient data. Treat those figures as research context, not a prediction of your own response or a service-specific success rate.¹ The clinician should explain the proposed treatment and the reason for selecting it.

What to compare before paying

Compare Basal Health for explicit introductory and continuing four-week charges and MaxLife for a starter-kit structure followed by a different renewal. Put the payment calendar and refund boundary beside each price rather than assuming every monthly label means the same purchase schedule.

For StaveMD, request four concrete answers: the exact medication and pharmacy, the initial charge, the next charge date and the point when the next medication order becomes nonrefundable. Those answers turn the published monthly offer into an individual plan that can be assessed for cost and flexibility.